PAVmed (PAVM) Research & Development (2015 - 2025)
PAVmed's quarterly Research & Development came in at $1.8 million in Q4 2025, up 126.52% year-on-year from $807000.0 in Q4 2024, and up 68.01% quarter-over-quarter from $1.1 million in Q3 2025.
PAVmed has reported Research & Development for 11 years, with the latest figure at $1.8 million in Q4 2025.
- For the quarter ending Q4 2025, Research & Development rose 126.52% year-over-year to $1.8 million; the trailing twelve-month figure through Dec 2025 stood at $4.5 million (down 43.72% YoY), and the FY2025 full-year result was $4.5 million, down 24.28% from the prior year.
- Research & Development for Q4 2025 stood at $1.8 million, up from $1.1 million in the prior quarter.
- The five-year high for Research & Development was $7.0 million in Q4 2021, with the low at $787000.0 in Q1 2025.
- Average Research & Development over 5 years is $3.6 million, with a median of $3.5 million recorded in 2023.
- Year-over-year, Research & Development sank 77.55% in 2024 and surged 126.52% in 2025.
- Tracing PAVM's Research & Development over 5 years: stood at $7.0 million in 2021, then slipped by 4.23% to $6.7 million in 2022, then sank by 46.13% to $3.6 million in 2023, then plunged by 77.55% to $807000.0 in 2024, then surged by 126.52% to $1.8 million in 2025.
- The last three Research & Development figures came in at $1.8 million (Q4 2025), $1.1 million (Q3 2025), and $790000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | 1.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 790,000.00 |
| Mar 31, 2025 | 787,000.00 |
| Dec 31, 2024 | 807,000.00 |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 1.94 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Sep 30, 2023 | 3.16 Mn |
| Jun 30, 2023 | 3.47 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Dec 31, 2022 | 6.67 Mn |
| Sep 30, 2022 | 6.20 Mn |
| Jun 30, 2022 | 6.74 Mn |
| Mar 31, 2022 | 5.93 Mn |
| Dec 31, 2021 | 6.97 Mn |
| Sep 30, 2021 | 5.31 Mn |
| Jun 30, 2021 | 4.26 Mn |
| Mar 31, 2021 | 3.32 Mn |
| Dec 31, 2020 | 3.64 Mn |
| Sep 30, 2020 | 2.62 Mn |
| Jun 30, 2020 | 2.13 Mn |
| Mar 31, 2020 | 2.63 Mn |
| Dec 31, 2019 | 2.25 Mn |
| Sep 30, 2019 | 1.52 Mn |
| Jun 30, 2019 | 1.41 Mn |
| Mar 31, 2019 | 1.45 Mn |
| Dec 31, 2018 | 1.37 Mn |
| Sep 30, 2018 | 1.17 Mn |
| Jun 30, 2018 | 1.15 Mn |
| Mar 31, 2018 | 563,218.00 |
| Dec 31, 2017 | 558,207.00 |
| Sep 30, 2017 | 704,866.00 |
| Jun 30, 2017 | 701,740.00 |
| Mar 31, 2017 | 656,713.00 |
| Dec 31, 2016 | 606,971.00 |
| Sep 30, 2016 | 578,474.00 |
| Jun 30, 2016 | 355,001.00 |
| Mar 31, 2016 | 179,141.00 |
| Dec 31, 2015 | 141,345.00 |
| Sep 30, 2015 | 264,532.00 |
| Jun 30, 2015 | 67,450.00 |
| Mar 31, 2015 | 16,000.00 |